Todd Brown is the primary endocrine consultant to the Johns Hopkins HIV Clinic. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients. He is the co-chair of the Executive Committee of the MACS WIHS Combined Cohort Study and has served in leadership positions for the ACTG. He has mentored multiple trainees from across the country and around the world in the area of HIV Comorbidities and Aging. He has published widely on the topic of HIV and endocrine conditions and lectures internationally on this and other issues related to metabolic diseases in HIV.
At the completion of this educational session, learners will:
- Understand the potential risks and benefits of testosterone treatment in the older cisgender male.
- Be familiar with the findings of the T Trials and the clinical questions that still remain.
- Understand what is known about the risks of testosterone for gender-affirming therapy in transgender men.
This CME activity has approved for
AMA PRA Category 1 Credit™ for November 11, 2020 as a live activity. This activity will also be available as an enduring activity from November 12, 2020, through November 10,2023.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.
- Dr. Todd T. Brown (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to Gilead, Janssen, Merck, Theatechnologies, and ViiV. Dr. Brown will support his presentation and clinical recommendations with the best available evidence from the medical literature and will submit his slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation
Download Article PDF/Slides